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Background: The risk factors for peripheral artery disease
(PAD) are more common in Indigenous than non-Indigenous
Australians; however, the presentation and outcomes of PAD
in Indigenous Australians have not been previously inves-
tigated. The aim of this prospective cohort study was to
compare the presenting characteristics and clinical outcomes
of Indigenous and non-Indigenous Australians with PAD.
Methods: Patients with PAD were prospectively recruited
since 2003 from an outpatient vascular clinic in Townsville,
Australia. Presenting symptoms and risk factors in Indige-
nous and non-Indigenous patients were compared using
Pearson’sChi-squared test andMann-WhitneyU test. Kaplan
Meier survival analysis and Cox proportional hazards anal-
ysis compared the incidence of myocardial infarction (MI),
stroke or death (major cardiovascular events) among Indige-
nous and non-Indigenous patients.
Results: A total of 401 PAD patients were recruited, of
which 16 were Indigenous and 385 were non-Indigenous
Australians. Indigenous Australians were younger at entry
(median age 63.3 (54.7–67.8) vs 69.6 (63.3-75.4)), more com-
monly current smokers (56.3%vs 31.4%), andmore frequently
had insulin-treateddiabetes (18.8%vs5.2%).Duringamedian
follow-up of 2.5 years, five and 45 combined events (MI,
stroke or death) were recorded amongst Indigenous and non-
IndigenousAustralians, respectively. IndigenousAustralians
were at a four-fold greater risk ofmajor cardiovascular events
(adjusted hazards ratio 4.03, 95% CI 1.17–13.87, p = 0.027)
compared to non-Indigenous Australians.
Conclusions: These findings suggest that Indigenous Aus-
tralians with PAD present at a younger age, have higher rates
of smoking and insulin-treated diabetes, and poorer clinical
outcomes compared to non-Indigenous Australians.
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Purpose: Rheumatic heart disease (RHD) remains a prob-
lem amongst Indigenous Australians, with many presenting
for surgery at a young age. Long-term outcomes of RHD
surgery amongst Indigenous Australians remain unreported.
Hence, this study aimed to describe outcomes of valvular
surgery for RHD in Indigenous Australians at a single centre.
Methods: Indigenous Australian patients with RHD and
who underwent valvular surgery (n = 112) between 2008 and
2016 were reviewed. Data were prospectively collected, and
follow-upwasobtained fromcardiologists.Multivariate anal-
ysis was performed to determine predictors of mortality.
Results: Mean age was 43± 16 years (range 13–73) with 82
(73%) being females. Surgery was performed on the mitral
valve in 93 (83%), aortic valve in 51 (46%), and tricus-
pid valve in 28 (25%) patients. In patients aged ≤50 years
(n = 73), there were 45 bioprosthetic (62%) valves implanted.
Operative mortality was 2.7%. Nine (8%) patients had reop-
eration for infective endocarditis (n = 3), bioprosthetic valve
degeneration (n = 4), mechanical valve thrombus (n = 1), and
progression of RHD in other valves (n = 1). There were 18
(16%) late deaths, and survival at 5 years was 83± 4.1 (95%
CI 73–89%). Risk factors formortalitywere concomitant coro-
nary artery bypass grafting (p= 0.008) and preoperative left
ventricular ejection fraction (LVEF) ≤40% (p= 0.043). The
mean follow-up for survivors was 5 years (2 months–9 years)
with 97% of patients in New York Heart Association class I or
II.
Conclusions:Valvular surgery forRHDin IndigenousAus-
tralians can be performed with low operative mortality. In
patients aged ≤50 years, bioprostheses were the valve of
choice. Concomitant coronary artery disease and LVEF ≤40%
were predictors of mortality.
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